Press release
Demand for Vancomycin To Expand At A CAGR of 5.8% Over 2027
The global vancomycin market is projected to increase from a valuation of US$ 313.7 Mn in 2020 to US$ 465.1 Mn by the end of 2027. Demand for vancomycin to expand at a CAGR of 5.8% during the forecast period.Demand for linezolid is set to increase at the highest CAGR over the forecast period with a broad spectrum of activity against many gram-positive bacteria.
The global vancomycin market is being driven by increased incidence of diseases caused by vancomycin-resistant Staphylococcus aureus (VRSA), and poor sanitation, which, in turn, increases the risk of hospital-acquired infections.
VRSA infections can be treated with a range of commercially available drugs, but maintaining basic sanitary conditions, including wound care, hand washing before and after direct contact with patients, and the use of disposable gloves, is the most effective strategy for preventing the spread of VRSA.
Download Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7293
Key Takeaways from Vancomycin Market Study
• Global vancomycin market to reach US$ 465.1 valuation Mn by 2027.
• Market in Germany projected to rise at a CAGR of 4% over the forecast period.
• Market in Canada to record 4.6% CAGR over the forecast period of 2021-2027.
• China vancomycin market forecast to reach size of US$ 102.3 Mn by 2027.
What Might Restrain Demand for Vancomycin to Some Extent?
"Rising Use of Generic Alternatives & Certain Side Effects Hampering Market Value"
Two typical adverse drug reactions associated with IV vancomycin are severe local pain and thrombophlebitis (which affect about 1% of patients). Clinical experiments conducted in the mid-1950s revealed that early impure versions of vancomycin tablets caused kidney damage (nephrotoxicity) and hearing loss (ototoxicity). Nephrotoxicity was discovered to be a rare adverse effect in later investigations using purer forms of vancomycin (0.1% to 1% of patients).
Certain limitations, such as rising use of generic alternatives, particularly as patents expire, and short lifecycle of medications, are expected to hinder vancomycin market growth.
To learn more about Vancomycin Market, you can get in touch with our Analyst
https://www.factmr.com/connectus/sample?flag=AE&rep_id=7293
Key Companies Profiled by Fact.MR
• Alvogen
• MGB Biopharma Limited
• Oragenics
• Aphios Corporation
• Microbiotix
Key Segments Covered in Vancomycin Industry Research
• Vancomycin Market by Type :
o Daptomycin
o Linezolid
o Quinupristin
o Ampicillin
o Chloramphenicol
o Others
• Vancomycin Market by Application :
o Sepsis
o Lung Infection
o Skin Soft Tissue Infection
o Colitis & Intestinal Inflammation
o Other Infections
• Vancomycin Market by Region :
o North America Vancomycin Market
o Europe Vancomycin Market
o Asia Pacific Vancomycin Market
o Latin America Vancomycin Market
o MEA Vancomycin Market
Get Free Access to this Report :
https://www.factmr.com/checkout/7293
Questionnaire answered in the Vancomycin Market report include:
• How the market for Vancomycin has grown?
• What is the present and future outlook of the global Vancomycin on the basis of region?
• What are the challenges and opportunities for the Vancomycin?
• Why the consumption of Vancomycin highest in region?
• In which year segment is expected to overtake segment?
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product modifications /Innovation
4. Key Success Factors
4.1. Strategic Developments
4.2. Key regulations
4.3. Product USPs /Technology
Contd…
Explore Fact.MR's More Insights on the Healthcare Domain
Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html
ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract--glaucoma-treatment-factmr-301262063.html
21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea
Phone: +1 (628) 251-1583
Email: sales@factmr.com
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed . Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we'll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Demand for Vancomycin To Expand At A CAGR of 5.8% Over 2027 here
News-ID: 2802789 • Views: …
More Releases from fact.mr

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics.
The market…

Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…

Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…

Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
More Releases for Vancomycin
Vancomycin Hydrochloride for Injection Market Size And Global Industry Forecast …
" The global market for Vancomycin Hydrochloride for Injection is valued at approximately $860 million in 2024, with a projected increase to around $1.4 billion by the end of 2034. This represents a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period from 2025 to 2034. "
Exactitude Consultancy., Ltd. released a research report titled "Vancomycin Hydrochloride for Injection Market". This report covers the global Vancomycin Hydrochloride for Injection…
Vancomycin Hydrochloride for Injection Market Size And Global Industry Forecast …
" The global market for Vancomycin Hydrochloride for Injection is valued at approximately $860 million in 2024, with a projected increase to around $1.4 billion by the end of 2034. This represents a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period from 2025 to 2034. "
Exactitude Consultancy., Ltd. released a research report titled "Vancomycin Hydrochloride for Injection Market". This report covers the global Vancomycin Hydrochloride for Injection…
Global Vancomycin Market Analysis 2025-2030: Growth Drivers, Challenges, And Opp …
The Vancomycin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Vancomycin Market Size Expected to Be by 2034?
The vancomycin market has expanded rapidly in recent years. It will grow from $0.82 billion in 2024 to $0.92 billion in 2025 at a…
Vancomycin Hydrochloride Manufacturing Project Cost: Industry Trends and Raw Mat …
Setting up a vancomycin hydrochloride plant facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Vancomycin Hydrochloride Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a vancomycin hydrochloride…
Impact Of Rising Infectious Disease Prevalence On The Vancomycin Market Driver: …
What Are the Projected Growth and Market Size Trends for the Vancomycin Market?
There has been a swift expansion in the size of the vancomycin market in the past few years. The market, which was valued at $0.82 billion in 2024, is projected to reach $0.92 billion by 2025, boasting a compound annual growth rate (CAGR) of 11.5%. The significant growth experienced in the historical period is credited to factors…
Vancomycin Market to see Rapid Growth by 2029
Vancomycin Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of % from 2024 to 2030. The Vancomycin market is witnessing significant growth, driven by its critical role in treating severe bacterial infections. As a potent antibiotic, Vancomycin is widely used to combat infections caused by Gram-positive bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus). With the increasing prevalence of…